相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The insulin resistance by triglyceride glucose index and risk for dementia: population-based study
Sangmo Hong et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan
Kuan-Chan Chen et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts
Galit Weinstein et al.
PLOS ONE (2019)
Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease
Maja Mustapic et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case control study
Ida Kim Wium-Andersen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors Versus Sulfonylureas: A Real-World Population-Based Cohort Study
Young-Gun Kim et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Contributing Factors to Diabetic Brain Injury and Cognitive Decline
Nirmal Verma et al.
DIABETES & METABOLISM JOURNAL (2019)
Metformin and the Risk of Dementia in Type 2 Diabetes Patients
Chin-Hsiao Tseng
AGING AND DISEASE (2019)
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
Mee Kyoung Kim et al.
DIABETES & METABOLISM JOURNAL (2019)
Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017
Samantha Wilkinson et al.
BMJ OPEN (2018)
Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis
Chin-Hsiao Tseng
JOURNAL OF CLINICAL MEDICINE (2018)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
Association Between the Use of Antihyperglycemic Drugs and Dementia Risk: A Case-Control Study
Jens Bohlken et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study
Chieh-Hsiang Lu et al.
DIABETOLOGIA (2018)
Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial
Suzanne Craft et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes
Ariela R. Orkaby et al.
NEUROLOGY (2017)
Bi-directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose-lowering agents: a systematic review and meta-analysis
K. Mattishent et al.
DIABETES OBESITY & METABOLISM (2016)
Analyses of Results From Cardiovascular Safety Trials With DPP-4 Inhibitors: Cardiovascular Outcomes, Predefined Safety Outcomes, and Pooled Analysis and Meta-analysis
Edoardo Mannucci et al.
DIABETES CARE (2016)
Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013 Nationwide population-based cohort study
Seung-Hyun Ko et al.
MEDICINE (2016)
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
W. N. Kernan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Comparison of the Usefulness of the Updated Homeostasis Model Assessment (HOMA2) with the Original HOMA1 in the Prediction of Type 2 Diabetes Mellitus in Koreans
Young Seok Song et al.
DIABETES & METABOLISM JOURNAL (2016)
Diabetes Mellitus and Dementia
Toshiharu Ninomiya
CURRENT DIABETES REPORTS (2014)
Diabetes Mellitus and the Risk of Alzheimer's Disease: A Nationwide Population-Based Study
Chin-Chou Huang et al.
PLOS ONE (2014)
Background and Data Configuration Process of a Nationwide Population-Based Study Using the Korean National Health Insurance System
Sun Ok Song et al.
DIABETES & METABOLISM JOURNAL (2014)
Neuronal damage and cognitive impairment associated with hypoglycemia: An integrated view
Gabriela Languren et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies
Kapil Gudala et al.
JOURNAL OF DIABETES INVESTIGATION (2013)
Impact and Therapeutic Potential of PPARs in Alzheimers Disease
Michael T. Heneka et al.
Current Neuropharmacology (2011)
Glucose tolerance status and risk of dementia in the community The Hisayama Study
T. Ohara et al.
NEUROLOGY (2011)
Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats
Bhupesh Sharma et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation Putative mechanism for aggravating vascular disease in diabetes
Rohana J. Wright et al.
DIABETES CARE (2010)
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Ralph A. DeFronzo
DIABETES (2009)
Incretin-based therapies for type 2 diabetes mellitus
Julie A. Lovshin et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Oral antihyperglycemic therapy for type 2 diabetes - Scientific review
SE Inzucchi
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
分享论文
